Michael F. Grunebaum, MD | Psychiatrist.com

Original Research

Effects of Ketamine on Neurocognition in Patients With Suicidal Ideation

November 2, 2021

This study investigated how ketamine affected cognitive test performance 1 day after administration in depressed patients with suicidal ideation.

John G. Keilp, Sean P. Madden, Julia E. Marver, et al

Commentary

Suicidology Meets "Big Data"

March 25, 2015

Michael F. Grunebaum

Article

Depressed Parents' Attachment: Effects on Offspring Suicidal Behavior in a Longitudinal Family Study

July 8, 2014

Erica K. MacGregor, Michael F. Grunebaum, Hanga C. Galfalvy, et al

Original Research

SSRI Versus Bupropion Effects on Symptom Clusters in Suicidal Depression: Post Hoc Analysis of a Randomized Clinical Trial

September 15, 2013

Michael F. Grunebaum, John G. Keilp, Steven P. Ellis, et al

Original Research

Omega-3 Polyunsaturated Fatty Acid (PUFA) Status in Major Depressive Disorder With Comorbid Anxiety Disorders

July 15, 2013

Joanne J. Liu, Hanga C. Galfalvy, Thomas B. Cooper, et al

Original Research

Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003

June 15, 2007

Atsuo Nakagawa, Michael F. Grunebaum, Steven P. Ellis, et al

Original Research

Moral Objections to Suicide: Can They Counteract Suicidality in Patients With Cluster B Psychopathology?

April 15, 2006

Kanita Dervic, Maria A. Oquendo, Dianne Currier, et al

Original Research

Antidepressants and Suicide Risk in the United States, 1985-1999

November 1, 2004

Michael F. Grunebaum, Steven P. Ellis, Shuhua Li, et al

Article

Medication Supervision and Adherence of Persons With Psychotic Disorders in Residential Treatment Settings: A Pilot Study

May 1, 2001

Michael F. Grunebaum, Peter J. Weiden, Mark Olfson